Our results show increased glucose uptake and elevated lipid droplet accumulation to be the major functional consequences of SPRY2 KO in these cells, as well as modifications to transcript levels of several genes and biological pathways relevant to the pathogenesis of metabolic diseases, such as obesity and T2DM. The gene discussed is SPRY2; the disease is Other metabolic disease.